CVE-2024-28793

IBM Engineering Workflow Management cross-site scripting

Description

IBM Engineering Workflow Management 7.0.2 and 7.0.3 is vulnerable to stored cross-site scripting. Under certain configurations, this vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 286830.

Category

4.9
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.14%
Vendor Advisory ibm.com Vendor Advisory ibmcloud.com
Affected: IBM Engineering Workflow Management
Published at:
Updated at:

References

Link Tags
https://www.ibm.com/support/pages/node/7154955 vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/286830 vdb entry vendor advisory
http://www.openwall.com/lists/oss-security/2024/05/24/2 third party advisory mailing list

Frequently Asked Questions

What is the severity of CVE-2024-28793?
CVE-2024-28793 has been scored as a medium severity vulnerability.
How to fix CVE-2024-28793?
To fix CVE-2024-28793, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-28793 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-28793 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-28793?
CVE-2024-28793 affects IBM Engineering Workflow Management.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.